| Role of vasopressor administration in patients with acute neurologic injury. | |
| | |
MedLine Citation:
|
PMID: 19387871 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION: Pharmacologic blood pressure elevation is often utilized to prevent or treat ischemia in patients with acute neurologic injury, and routinely requires administration of vasopressor agents. Depending on the indication, vasopressor agents may be administered to treat hypotension or to induce hypertension. METHODS: Although numerous guideline statements exist regarding the management of blood pressure in these patients, most recommendations are based largely on Class III evidence. Further, there are few randomized controlled trials comparing vasopressor agents in these patients and selection is often guided by expert consensus. RESULTS: We discuss the clinical evidence regarding vasopressor administration for blood pressure management in patients with acute neurologic injury. The effect of various vasopressors on cerebral hemodynamics is also discussed. CONCLUSION: Although high-quality clinical data are scarce, the available evidence suggests that norepinephrine should be considered as the vasopressor of choice when blood pressure elevation is indicated in patients with acute neurologic injury. |
| | |
Authors:
|
Katie M Muzevich; Stacy A Voils |
Publication Detail:
|
Type: Journal Article; Review Date: 2009-04-22 |
Journal Detail:
|
Title: Neurocritical care Volume: 11 ISSN: 1541-6933 ISO Abbreviation: Neurocrit Care Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-07-07 Completed Date: 2009-09-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101156086 Medline TA: Neurocrit Care Country: United States |
Other Details:
|
Languages: eng Pagination: 112-9 Citation Subset: IM |
Affiliation:
|
Virginia Commonwealth University Health System, Richmond, VA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Brain Diseases / drug therapy* Brain Injuries / drug therapy* Humans Intensive Care* Spinal Cord Injuries / drug therapy* Vasoconstrictor Agents / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Vasoconstrictor Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mass Spectrometry Identifies LGI1-Interacting Proteins that Are Involved in Synaptic Vesicle Functio...
Next Document: FSHbeta knockout mouse model: a decade ago and into the future.